|
Detailed information for selected cell line:
| Cell Line: |
CSES22; abnormal karyotype
|
| NIH Registration Number: |
0119
|
| NIH Approval Number: |
NIHhESC-11-0119
|
| Available for Distribution: |
No
|
| Provider Restrictions: |
HESC recipients must provide documentation of ESCRO, IRB or equivalent ethical review for the research planned with the requested cell lines.
|
| Additional Information: |
The karyotype for this cell line is 47,XX,+16 (15), 47,XX,+15 (2), 46,XX, t(16;22) (1), 47,XX,+5, t(16;22) (1), 46,XX (1).
|
| NIH Restrictions: |
(No Additional Restrictions)
|
| Submitting Organization: |
Cedars-Sinai Medical Center |
| Provider Name: |
Dhruv Sareen, Ph.D.
|
| Provider Phone: |
(310) 423-7074
|
| Provider Email: |
ipsccore@cshs.org
|
| Provider URL: |
http://cedars-sinai.edu/Research/Research-Cores/Induced-Pluripotent-Stem-Cell-Core-/index.aspx
|
| Approval Date: |
06/10/2011 |
View All Lines Eligible for Use
Go to NIH Form 2890 Login Page
Go to NIH Stem Cell Information Page
| |
NIH Form 2890:
- Login
Page
(Authorization Required)
Contact Us:
- Email questions to:
hescregistry@mail.nih.gov
(Emails that are offensive or unrelated to stem cells will be
deleted.)
|
| |
|
Warning! This browser is not supported - Some features might not work. Try using a different browser such as Chrome, Edge, Firefox, or Safari.
NIH Staff 
